Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Fabo, E. C.
Right arrow Articles by Broemeling, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Fabo, E. C.
Right arrow Articles by Broemeling, L. D.

The Journal of Nutrition Vol. 127 No. 11 November 1997, pp. 2158-2164
Copyright ©1997 by the American Society for Nutritional Sciences

Dietary L-Histidine Regulates Murine Skin Levels of Trans-Urocanic Acid, an Immune-Regulating Photoreceptor, with an Unanticipated Modulation: Potential Relevance to Skin Cancer1,2

Edward C. De Fabo3, Lindsay J. Webber, Edward A. Ulman*, and Lyle D. Broemelingdagger

Department of Dermatology, The George Washington University Medical Center, Washington, DC 20037; * Research Diets, New Brunswick, NJ 08901; and dagger  Biostatistics Center Medical Center Unit, The George Washington University Medical Center, Washington, DC 20037

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
ACKNOWLEDGMENTS
FOOTNOTES
LITERATURE CITED


ABSTRACT

Solar ultraviolet-B radiation (UVB; 290-320 nm) causes skin cancer and suppresses cell-mediated immunity, preventing the rejection of UV-induced tumors. One mechanism initiating UV suppression involves the trans to cis photoisomerization of urocanic acid (UCA), a histidine derivative found in the stratum corneum. The addition of L-histidine to nonpurified mouse diet has been shown to increase skin trans-UCA levels and sensitivity to UVB immune suppression. Specially formulated L-histidine diets (0.40-64 g/kg) fed to BALB/c mice that were monitored over a 19-wk period resulted in an unexpected modulation of skin trans-UCA. ANOVA revealed a group-time interaction, providing initial evidence that the skin levels of trans-UCA were modulating up and down in all groups except the control group (6.4 g/kg diet). We observed that both high (64 g/kg diet) and low (0.4 g/kg diet) levels of dietary L-histidine resulted in the increase of skin trans-UCA to levels significantly higher than those recorded in the control group. In mice fed these histidine levels, skin trans-UCA increased to between 2.9 and 3.6 nmol/mg skin (64 g/kg diet, over 5 wk; 0.4 g/kg diet, over 8 wk) and then decreased to ~1.69 nmol/mg skin, the base-line level (64 g/kg diet, over 11 wk; 0.4 g/kg diet, over 17 wk). The increase in trans-UCA levels in mice with low L-histidine intake may be the result of protein malnutrition, consistent with weight loss observed in those mice. The modulation of trans-UCA levels in skin by dietary L-histidine has not been previously described; its role in skin cancer development is under investigation.

KEY WORDS: ultraviolet-B radiation · urocanic acid · L-histidine · BALB/c mice · immunosuppression


INTRODUCTION

Solar ultraviolet-B (UVB4; 290-320 nm), the shortest rays of nonionizing sunlight able to penetrate to the earth's surface, cause malignant transformation of cells (Black and Chan 1977, Forbes et al. 1978), and a selective systemic suppression of cell-mediated immunity (De Fabo and Noonan 1983, Noonan et al. 1981). UVB-induced immune suppression is a critical step in UV-carcinogenesis that prevents the immunologic rejection of highly antigenic UV-induced tumors (De Fabo and Kripke 1979, Fisher and Kripke 1982, Noonan and De Fabo 1992).

Our studies of the systemic suppression of contact hypersensitivity by prior UV irradiation are focused on understanding how UV radiation induces immune suppression. A previous experiment revealed a unique photoreceptor in skin that appears to control the initiation of the immune suppressive action of solar UVB (De Fabo and Noonan 1983b). The photoreceptor was identified as urocanic acid (UCA), which is formed on deamination of the essential amino acid L-histidine, via the catalytic action of the enzyme histidine-ammonia lyase (histidase, EC 4.3.1.3). Our working hypothesis for UVB-induced immune suppression proposes that absorption of UVB by trans-UCA leads to photoconversion to the cis isomer. cis-UCA initiates an "alteration" in antigen-presenting cells (APC, e.g., skin Langerhans cells, macrophages, lymph or spleen dendritic cells) such that antigen-specific down-regulatory T cells, rather than effector T cells, are formed as antigen is processed by the altered APC (De Fabo and Noonan 1983b, Greene et al. 1979). Evidence supporting this model continues to accumulate (see reviews in Noonan and De Fabo 1992, Norval 1996). We propose that, as the suppressor to effector T-cell ratio increases, down-modulation of an immune response against the sensitizing antigen occurs. If UV-induced skin tumor antigens are involved in skin malignancies (Hostetler et al. 1995), suppression of immune attack by cis-UCA against skin cells carrying these antigens is predicted to occur, allowing tumor outgrowth. It is this alteration of antigen-presenting cells and antigen processing by cis-UCA that we propose links UVB and UCA isomerization to systemic immune suppression and skin cancer. If this scenario is correct, the following question arises: can modified trans-UCA levels in the skin, formed in mice fed different dietary L-histidine, affect skin tumor development?


Fig. 1. Concentrations of skin trans-urocanic acid (trans-UCA) in BALB/c mice fed as follows for the 19-wk feeding period: Group A, 0.4 g L-histidine/kg diet; Group B, 1.6 g L-histidine/kg diet; Group C (control), 6.4 g L-histidine/kg diet; Group D, 25.6 g L-histidine/kg diet; Group F, 64 g L-histidine/kg diet. Values are means ± SEM; n = 3. Base-line levels are indicated by the solid line at 1.69 nmol/mg skin trans-UCA (mean level of all groups before feeding special diets).
[View Larger Version of this Image (25K GIF file)]

Table 1. The L-amino acid-based diets used in this study1

[View Table]

Table 2. One-way ANOVA to compare skin trans-UCA levels among all dietary groups at each time point1

[View Table]


Fig. 2. Median skin trans-urocanic acid (trans-UCA) concentration in BALB/c mice fed as follows for the 19-wk feeding period: Group A, 0.4 g L-histidine/kg diet; Group B, 1.6 g L-histidine/kg diet; Group C (control), 6.4 g L-histidine/kg diet; Group D, 25.6 g L-histidine/kg diet; Group F, 64 g L-histidine/kg diet. The LOWESS curve (a locally weighted scatter plot smoother) is plotted for each group.
[View Larger Version of this Image (15K GIF file)]

One of our earlier studies showed that increased dietary L-histidine (100 g/kg nonpurified diet) leads to increased levels of mouse skin trans-UCA and increased sensitivity to UVB-induced immune suppression (Reilly and De Fabo 1991). This suggests that increased UVB immune suppression by L-histidine may play a role in skin cancer development.


Fig. 3. Body weight (g) (values are means ± SEM) over the 19-wk feeding period of BALB/c mice fed as follows: Group A, 0.4 g L-histidine/kg diet; Group B, 1.6 g L-histidine/kg diet; Group C (control), 6.4 g L-histidine/kg diet; Group D, 25.6 g L-histidine/kg diet; Group F, 64 g L-histidine/kg diet.
[View Larger Version of this Image (20K GIF file)]

Table 3. Results from a first-order linear regression fitted to the mouse body weight data for each dietary group as shown in Figure 3

[View Table]


MATERIALS AND METHODS

Mice. Female BALB/c AnNCr mice were used (National Cancer Institute, Frederick Cancer Research Facility, Frederick, MD). All animals were kept under a strict 12-h light:dark cycle and were 8 wk old at the start of the experiment. The protocol for animal use was reviewed and approved by the Institutional Animal Care and Use Committee of The George Washington University.

Specialized L-histidine diet. Mice were given free access to pelleted, low fat, L-amino acid-based diets (Research Diets, New Brunswick, NJ) modified from Baker and Boebel (1981) (see Table 1). The specified amounts of L-histidine were added at the expense of cornstarch. Thus, the diets were not isonitrogenous, but all other nutrients were equal. To make the diets isonitrogenous, we would have had to add to our diet either a single nonessential amino acid or mix of such, which in either case would result in adding compounds with unknown consequences for UCA formation in the skin.

Feeding groups. For 19 wk, five groups of 60 mice were fed the pelleted food (Table 1) containing the following levels of L-histidine: Group A, 0.4 g/kg diet; Group B, 1.6 g/kg diet; Group C (control group), 6.4 g/kg diet; Group D, 25.6 g/kg diet; and Group E, 102.4 g/kg diet. Five weeks into the experiment, it was noticed that the highest dose of L-histidine (Group E) was not well tolerated; at wk 10, this group was terminated because the mice continued to show severe signs of debilitation. Group E was replaced with a new group of mice fed a 64 g L-histidine/kg diet (Group F). This new level was well tolerated and was continued for a total feeding period of 19 wk.

UCA extraction. Three mice were removed weekly from each feeding group for skin UCA level determination. The level of trans-UCA for all groups was measured at wk 0, before the customized diets were introduced. The mice were killed with halothane vapor and, under a yellow safe light (nonphotoisomerizing to UCA) that blocked UVA and UVB radiation to a level of less than 10-6 W/cm2, the dorsal surface of each mouse was shaved using electric clippers, exposing ~10 cm2 of skin. The shaved dorsal skin was dissected off, the subcutaneous fat removed by scraping with a scalpel blade and three punch biopsies (each 6 mm in diameter) were taken from each skin sample. The biopsy pieces from each mouse were wrapped together in preweighed aluminum foil to exclude any light, placed in a plastic bag on ice and transported to an analytical balance for weighing. The samples were then placed back under the yellow safe light, removed from the aluminum foil and the extraction protocol followed (see below).

Extraction protocol. A modification of an extraction for UCA in human skin was used, as previously described (Jansen et al. 1991, Reilly and De Fabo 1991). In brief, each sample was diced finely with scissors into a 1.5-mL microcentrifuge tube (Fisher Scientific, Pittsburgh, PA) containing 100 µL of 1 mol/L KOH. Each sample tube was mixed with a vortex mixer and then placed on ice for a 10-min extraction period. The remainder of the extraction protocol was conducted under regular laboratory lighting (OCTRON 4100K 32W; Sylvania, St. Mary's, PA), and all samples were kept in the dark by covering with aluminum foil while on the bench top. Each sample tube was centrifuged for 5 min (16,300 × g) after which the supernatant was transferred to a clean tube, referred to as the extract tube. A second 100 µL of 1 mol/L KOH was added to the skin pellet and the procedure repeated. The skin pellet remaining in the sample tube was then washed with 200 µL of HPLC-grade distilled water (Fisher Scientific), the washings added to the extract tube and the extract neutralized with 200 µL 0.67 mol/L H3PO4. At this point, the covered extract tubes were placed at -70°C. When all of the samples had been extracted for UCA and stored at -70°C, HPLC was carried out. Random sampling of the pellets remaining after extraction showed that no detectable levels of UCA could be found.

High performance liquid chromatography. On removal from the -70°C freezer, the covered samples were thawed slowly at room temperature. The extract tubes were then centrifuged for 5 min (16,300 × g ) and 100 µL removed for analysis. Each 100-µL sample was diluted with 400 µL of acetonitrile and phosphate buffer (ACNP) [1 L ACNP = 800 mL HPLC-grade acetonitrile (Fisher Scientific) + 198 mL HPLC-grade distilled water + 2 mL phosphate buffer (49.0 mL 1 mol/L K2HPO4 + 51.0 mL 1 mol/L KH2PO4; pH = 6.8)]. Analysis was conducted using HPLC (Beckman System Gold Model 126, Beckman Bioanalytical Systems Group, Columbia, MD) with an Ultrasil-NH2 column (#235345). ACNP buffer was used as the eluant in isocratic phase. Purified cis-UCA (provided by Irma Santucci and John Finlay-Jones, Flinders University, Australia) and trans-UCA (Fisher Scientific), dissolved in ACNP (1.0 ng/µL), were used as standards. Throughout the procedure, great care was taken to minimize any exposure of the extracted tissue or extraction solution to room or window light to prevent isomerization of UCA (Hug and Hunter 1994) by keeping the tubes covered whenever possible.

Curve fitting. The mean of trans-UCA values, at wk 0, is expressed in Figure 1 as a base line for comparative purposes. The lines plotted through the data points were calculated using a curve-fitting program (TableCurve, 2D v 3, Jandel, San Rafael, CA).

Body weights. Each week, the mice remaining in the five feeding groups were weighed. The mice were placed in a preweighed container, in groups of up to 5, and weighed using an Ohaus triple beam balance (Florham Park, NJ). The average weight of the mice in each feeding group was calculated and used to monitor weekly changes in body mass. To assess the overall change in weight for Groups A-F throughout the experiment (19 wk), a first-order linear regression was fitted to the data and the F statistic used to indicate the significance of the slopes from zero at the level of P < 0.05.

Statistical analysis. This study was designed as a two-factor factorial experiment, with time and dietary group as the two factors, in which three mice were used in each group for each week. Preliminary statistical analysis consisted of plotting the median trans-UCA level separately for each group (A-F) at each week over the 19-wk period. A LOWESS curve (Cleveland 1979), a locally weighted scatter plot smoother, was used to plot the trans-UCA level for three mice for each group at each week over the 19-wk period. A two-way ANOVA was used to analyze the data, and a significant group by time interaction was found. The five groups were compared at each week with a one-way ANOVA followed by the Scheffé multiple comparison procedure (Woolson 1987). The probability level at which differences were considered significant was P < 0.05.


RESULTS

Skin urocanic acid levels. The levels of skin trans-UCA recorded in each feeding group are shown in Figure 1. In the control group (Group C; 6.4 g L-histidine/kg diet), the levels of skin trans-UCA recorded (1.45-2.18 nmol/mg) were consistent with those routinely found in BALB/c mice fed a diet of laboratory rodent pellets (PMI Feeds, St. Louis, MO., 5.5 g L-histidine/kg diet; data not shown). In Group A (0.4 g L-histidine/kg diet), in which mice were given a level of L-histidine 94% lower than control, skin trans-UCA levels exceeding base line were observed from ~2 to 14 wk. In Group B (1.6 g L-histidine/kg diet), in which the L-histidine concentration was 75% lower than control, skin trans-UCA levels were noted to be above the base-line level between ~wk 5 and 14. In Group D (25.6 g L-histidine/kg diet), in which the L-histidine concentration was four times the control, again skin trans-UCA levels appeared to modulate slightly above the base-line level in a manner not unlike that seen in Group B between ~wk 4 and 14. In Group F (64 g L-histidine/kg diet), in which the L-histidine concentration was 10 times the control, skin trans-UCA levels modulated well above the base-line level. Interestingly, the mice in Group F appeared to have two maximum levels of trans-UCA (3.26-3.62 nmol/mg skin), the first at about 5 wk and the second at about 15-17 wk. As noted earlier, Group E (102.5 g L-histidine/kg diet) was terminated at the end of 10 wk because of severe toxic reactions to this level of L-histidine. The level of trans-UCA at that time was ~4.35 nmol/mg skin.

Statistical analysis. Statistical analysis gave initial evidence that the trans-UCA level was modulating for those groups with dose levels of L-histidine lower and higher than the control group (Group C). A graph of median trans-UCA concentration in the skin of the five groups (Fig. 2) shows a group-time interaction. The graph suggests that the control group averages were less than those of the two extreme groups, i.e., the lowest and highest L-histidine dose groups (Groups A and F, respectively). A two-way ANOVA showed a significant group by time interaction (see Table 2). A general pattern was revealed in which the control group differed from the two extreme L-histidine dose groups in skin trans-UCA concentration (A and F).

Body weights. The mean weights recorded for the mice in each feeding group, as described in Materials and Methods, are shown in Figure 3. All mice, except those in Group A, showed an overall increase in weight by the end of the experiment (see Table 3) as determined by the percentage change from wk 0 to the end of the experiment (wk 19). Further, the slopes of the regression lines for all groups, except Group A, were positive, indicating a weight gain during the 19-wk period. The negative slope for Group A indicated an overall loss in weight in that group. For all groups, the slopes of the lines were significantly different from zero (P < 0.0001; see Table 3).


DISCUSSION

This study was designed to determine if defined diets containing varying amounts of L-histidine would alter the base-line levels of trans-UCA in the skin of BALB/c mice. UCA is formed by the action of histidine ammonia lyase (EC 4.3.1.3) in a single-step deamination of L-histidine. L-Histidine concentrations from 94% below to 900% above normal dietary histidine concentration were fed to mice for 19 wk, and an unexpected up and down modulation of skin trans-UCA levels was observed. Modulation in skin trans-UCA levels occurred in all groups except those fed normal levels of histidine (6.4 g/kg) (Fig. 1). We observed that both high (64 g/kg diet) and low (0.4 g/kg diet) levels of dietary L-histidine resulted in an increase of skin trans-UCA to levels significantly higher than those of the control group.

The reason for the observed modulation in skin trans-UCA levels by the various concentrations of dietary L-histidine is unknown. One possibility is that an unusual type of feedback inhibition mechanism is involved. However, the modulation of skin trans-UCA levels occurs over weeks instead of the much shorter periods of time expected in simple feedback inhibition.

Interestingly, in in vitro studies, Wright et al. (1982) found two components of histidine-ammonia lyase in partially purified liver extracts from normal mice. One showed 50% lower enzyme activity at high L-histidine concentrations. At low L-histidine concentrations, sigmoidal kinetics were observed. This in vitro study, although not identical to our in vivo results, indicates a complex interaction between histidase and its substrate, histidine, suggesting a concentration-dependent interaction that would be consistent with our findings.

Another possible scenario involves the formation of filaggrin, a histidine-rich protein (10-12% histidine) associated with the keratinization of skin (Scott et al. 1982). Because skin keratinization occurs in mouse skin, mechanisms controlling this reaction may be influenced by different concentrations of dietary L-histidine. Because L-histidine from filaggrin may be at least one of the precursors of trans-UCA in skin during keratinization (Scott et al. 1982), changes in dietary L-histidine may influence the concentration of filaggrin formed. This does not explain, however, the modulation of skin trans-UCA observed in our study. It does, nonetheless, leave open the possibility that keratinization may be influenced by changes in histidine intake.

Another unexpected observation in the study reported here is that in Group A, in which the dietary L-histidine concentration was 94% below control levels, a contradiction arose. It is difficult to explain the trans-UCA levels nearly 100% greater than base line in mice with such a low dietary intake of L-histidine (0.4 g/kg diet). One possibility is that the mice in group A were malnourished. With such low L-histidine intake, the physiologic need for this amino acid may induce a major metabolic readjustment such that it becomes available through body protein catabolism (e.g., muscle). Such a condition could help explain the observed increase in trans-UCA levels and the significant weight loss in Group A mice (Fig. 1 and 3, respectively). Precedent for this may be seen in malnourished humans. Several studies have shown that in protein malnutrition (e.g., kwashiorkor), there is also a loss in weight and large amounts of UCA are excreted in urine along with abnormal histidase activity in the liver, most likely as a result of unusually high levels of L-histidine being released by tissue breakdown (Antener et al. 1983, Whitehead 1964, Whitehead and Arnstein 1961).

Dietary L-histidine and skin cancer. Ultraviolet radiation-induced alterations to DNA (Black and Chan 1977, Forbes et al. 1978) and initiation of immune suppression (De Fabo and Noonan 1983a and 1983b, Noonan et al. 1981) play critical roles in photocarcinogenesis (De Fabo and Kripke 1979, Fisher and Kripke 1982, Noonan and De Fabo 1992). Dietary factors are also important in skin cancer formation (Black et al. 1992, Orengo et al. 1989, Reeve et al. 1988, Scotto and Fears 1987). The complete dietary ingredients used in this study are listed in Table 1. Although we are unaware of studies concerning effects of specific amino acids on skin cancer, certain unsaturated fatty acids, e.g., corn oil [(n-6) fatty acid source], have been shown to promote UV carcinogenesis in mice. Others, however, such as menhaden oil [(n-3) fatty acid source] protect against UV carcinogenesis (Black et al. 1985, Orengo et al. 1989). The mechanism involved appears to be related to the induction of prostaglandin E2, an immunosuppressive agent, by corn oil but not by menhaden oil. Taking this into consideration, the concentration of corn oil was constant in all diets used throughout these experiments (10 g/kg) (Fisher and Black 1991).

Data from these experiments suggest a previously unknown type of in vivo modulation of skin trans-UCA by L-histidine. As pointed out above, trans-UCA is a sunlight-activated, immune modulating skin photoreceptor that plays a role in skin cancer induction (De Fabo and Noonan 1983a and 1983b, Noonan and De Fabo 1992). Therefore the question becomes, does modulation of trans-UCA by dietary L-histidine play a role in UV-induced skin cancer? We previously showed that upon exposure to UV radiation, trans-UCA in the skin photoisomerizes to cis-UCA, which initiates an antigen-presenting cell defect resulting in immunosuppression (Noonan et al. 1988). This form of immunosuppression appears to play a major role in subcarcinogenic doses of UV radiation preventing immunological rejection of UV-induced skin cancers (De Fabo and Kripke 1979).

The modulation of skin trans-UCA by dietary L-histidine as described here, when coupled with exposure to UVB radiation of mouse skin, could change. The direction and magnitude of such a putative change are unknown at this time. However, different levels of the cis isomer of UCA, the immune suppressing form, would be expected to occur. If excessive amounts of cis-UCA develop, interaction with "tumor antigens" associated with UVB-induced malignant transformation (Hostetler et al. 1995) would be expected to increase. This, in turn, would lead to an increase in the formation of antigen-specific T-suppressor cells against the tumor antigen, via cis-UCA-induced alterations to antigen-presenting cell function as described previously (see Noonan and De Fabo 1992). Such interaction would allow the outgrowth of the malignantly transformed skin cells by preventing their immunologic rejection. Thus, continued exposure to UVB radiation, along with changing skin UCA levels caused by either high or low dietary L-histidine, may result in enhanced levels of tumor-specific suppressor T-cells and hence accelerated tumor outgrowth. We reported earlier that increased dietary L-histidine can lead to greater immune suppression for a given amount of UVB radiation (Reilly and De Fabo 1991). Others have reported direct association between the amount of exogenously applied trans-UCA and increased UV-induced skin cancer (Reeve et al. 1989). Whether changes in dietary L-histidine such as in this study will affect UV-induced skin cancer induction is currently under investigation.

Finally, it is of interest to note that L-histidine is considered to be an essential amino acid for humans and, as such, is required in the diet. The average amount of L-histidine consumed by an adult male is ~1.6 g/day (or 1.6% of total protein intake), a level 90-220% higher than the 0.5-0.84 g/day dietary requirement for adults established by WHO (1985) (Life Science Research Office 1992). In view of the findings reported here, to assess a putative role for L-histidine in skin cancer, we are currently irradiating BALB/c mice fed diets as described in this paper with photocarcinogenic levels of UV radiation. Verification that dietary L-histidine level plays a role in skin cancer outgrowth would establish a previously unknown link between a specific dietary amino acid and UV-induced skin cancer.


ACKNOWLEDGMENTS

We gratefully acknowledge the expert technical assistance of Cynthia M. Roldan and Vi Dang, and we thank Frances P. Noonan and Bernard Bouscarel for their excellent critical review of the manuscript.


FOOTNOTES

1   Supported in part by grant 94A16 from the American Institute for Cancer Research (E.C.D.) and in part by grant RO1CA53793 (E.C.D.) from the National Cancer Institute, National Institutes of Health, Bethesda, MD.
2   The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
3   To whom correspondence should be addressed.
4   Abbreviations used: ACNP, acetonitrile and phosphate buffer; APC, antigen-presenting cell; dietary L-histidine groups (g/kg diet): A, 0.4; B, 1.6; C (control), 6.4; D, 25.6; E, 102.4; F, 64; UCA, urocanic acid; UVB, ultraviolet B.

Manuscript received 13 January 1997. Initial reviews completed 20 March 1997. Revision accepted 4 August 1997.


LITERATURE CITED


0022-3166/97 $3.00 ©1997 American Society for Nutritional Sciences




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Fabo, E. C.
Right arrow Articles by Broemeling, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Fabo, E. C.
Right arrow Articles by Broemeling, L. D.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]